Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026
Business Wire•27/10/2026•06:30 ET
0
Key Highlights
- ➤Compass Pathways will release Q3 2026 results on November 3, 2026.
- ➤Management will host an 8:00 am ET conference call on November 3, 2026.
- ➤COMP360 psilocybin is under evaluation for treatment-resistant depression and PTSD.
- ➤Compass is executing a late-stage COMP360 trial evaluating PTSD treatment.
Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that it will release financial results for the third quarter ended September 30, 2026, and provide an update on recent developments, on November 3, 2026.
Get started
Create a free account to read the full story.